Next-generation monoclonal antibodies (mAbs), including bispecifics and multimerized formats, present increasingly complex purification challenges. Unique structural features and elevated impurity ...

The landscape of novel monoclonal antibody (mAb) therapeutic formats has expanded significantly in recent years, introducing new challenges in the purification process. Traditional full-length IgG ...

Matt Taylor is a senior process development associate at KBI Biopharma, where he focuses on the design, optimization, and scale-up of purification processes for biopharmaceutical manufacturing. Matt ...

The session will explore the market growth of complex molecules, driven by advances in personalized medicine and biotechnology. We will identify key drivers and discuss the primary challenges in ...